Introduction to ESMO 2025 Genitourinary Cancer Abstracts ESMO 2025 genitourinary cancer abstracts show exciting new finds. For instance, they include…
Browsing: Bladder Cancer
Genitourinary oncology is advancing fast. At the MOASC Spotlight on Oncology event on August 16, 2025, at VEA Newport Beach,…
Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBC Date: February 14, 2025 Author: Dr. Matthew I. Milowsky, MD,…
… Dr. Sumanta (Monty) Kumar Pal, M.D., FASCO highlights some of the top data and presentations being presented in kidney and…
The “MOASC SPOTLIGHT ON ONCOLOGY – GU ASCO UPDATES” seminar, led by Dr. Nataliya Mar, Clinical Associate Professor in the…
Bladder Cancer Test: Does GALEAS Bladder aid in the early detection of bladder cancers? Prof. Bryan Dr. Ward Professor…
Bladder cancer test called “GALEAS Bladder” is a DNA-based diagnostic urine test designed to aid in the early detection of…
iFrame is not supported! Pembrolizumab combined with CG0070. How can this help patients with NMIBC? Roger Li Roger Li, MD…
rAd-IFNα/Syn3 Phase 3 Trial NMIBC [2022] rAd-IFNα/Syn3 Bladder Cancer Trial It’s an honor to be asked to speak about…